Simetrija - Company finances
|
EUR
|
2023
From: 2023-08-14
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | - | 12,979 | 24,596 |
| Profit before tax | -2,884 | -19,026 | 1,609 |
| Net profit | -2,884 | -19,026 | 1,609 |
| Equity | -1,884 | -20,910 | -19,300 |
| Liabilities | 7,500 | 28,276 | 27,766 |
| Non-current assets | 0 | 180 | 180 |
| Current assets | 5,616 | 7,186 | 8,286 |
| Total assets | 5,616 | 7,366 | 8,466 |
|
Taxes paid
|
|||
| STI taxes | - | 3,462 | 6,759 |
|
Financial indicators
|
|||
| Revenue change y/y | - | - | +89.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -51.4% | -258.3% | 19.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -146.6% | 6.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -146.6% | 6.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 11,799 | 24,596 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Simetrija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-25 | 49.01 |
| 2026-06-11 | 2026-06-15 | 6.89 |
| 2026-06-02 | 2026-06-08 | 6.89 |
| 2026-01-16 | 2026-01-25 | 63.28 |
| 2026-01-01 | 2026-01-15 | 24.68 |
| 2025-10-16 | 2025-10-16 | 80.98 |
| 2025-10-01 | 2025-10-15 | 10.79 |
| 2025-09-16 | 2025-09-28 | 8.53 |
| 2024-08-27 | 2024-09-02 | 63.08 |
| 2024-08-19 | 2024-08-26 | 98.24 |
| 2024-08-01 | 2024-08-18 | 63.08 |
| 2024-07-16 | 2024-07-30 | 33.74 |
| 2024-07-03 | 2024-07-11 | 48.37 |
| 2024-07-02 | 2024-07-02 | 82.11 |
| 2024-06-18 | 2024-07-01 | 17.61 |
| 2024-01-03 | 2024-01-31 | 58.63 |
| 2023-12-01 | 2023-12-28 | 175.89 |
| 2023-11-03 | 2023-11-30 | 117.26 |
| 2023-10-03 | 2023-11-02 | 58.63 |
Simetrija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-03 | 2026-04-14 | 0.06 |
| 2025-05-20 | 2025-05-24 | 0.66 |
| 2025-05-05 | 2025-05-19 | 0.6 |
| 2025-05-03 | 2025-05-04 | 406.55 |
| 2025-05-01 | 2025-05-02 | 406.6 |
| 2025-04-28 | 2025-04-30 | 406.05 |
| 2025-04-03 | 2025-04-27 | 0.05 |
| 2025-03-28 | 2025-04-02 | 0.07 |
| 2025-03-19 | 2025-03-19 | 0.07 |
| 2025-03-15 | 2025-03-18 | 0.12 |
| 2025-03-03 | 2025-03-14 | 70.36 |
| 2025-03-02 | 2025-03-02 | 0.12 |
| 2025-02-28 | 2025-02-28 | 416.79 |
| 2024-10-01 | 2024-10-13 | 0.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Simetrija, MB (code 306379243) is a Small partnership engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €24.6K and net profit of €1.6K, which corresponds to a 6.5% profit margin. Revenue increased by 89.5% year on year, showing a clear improvement in trading activity. The profit result also moved sharply from a loss in 2024 to a positive outcome in 2025. In 2023, during a 139-day period, the company reported a net loss of €2.9K, followed by a larger loss of €19.0K in 2024, before returning to profit in 2025. At the end of 2025, total assets stood at €8.5K, with equity at -€19.3K and liabilities at €27.8K. Long-term assets were €180 and short-term assets €8.3K. Asset turnover was 2.91x, and revenue per employee was €24.6K, with profit per employee of €1.6K. Profitability ratios should be viewed in the context of negative equity.